Elise Wang, MBA
Partner, Deerfield Management Company

Elise Wang has been a member of our board of directors since December 2020. Ms. Wang is currently a Partner on the Structured Finance group at Deerfield Management Company, L.P., and has been with Deerfield since 2010. Ms. Wang currently serves on the board of Jaguar Gene Therapy and previously served on the board of Orchard Therapeutics. Prior to joining Deerfield, from 2001 to 2007, Ms. Wang was a Senior Research Analyst and Managing Director in healthcare primarily covering the biotechnology industry at Citigroup. From 1996 to 2001, Ms. Wang was a Senior Research Analyst and Managing Director at PaineWebber Inc., where she covered biotechnology. Ms. Wang began her career in healthcare in 1987 as a venture capitalist and banker at PaineWebber Inc. and was an officer of PaineWebber Development Corporation, which managed entities invested in biotechnology and high technology companies. Ms. Wang holds an A.B. in Engineering Sciences with a specialty in Biomechanics from Harvard University and an M.B.A. from Harvard Business School.